Transmeta is also focusing on the handheld device market, which is where it should be. And no one paid much attention to the fact that, just before the IPO, IBM backed off its promises to use the chip. And others will do so at any hint that Transmeta-based portables cannot compete. And it can't. Not more speed, like AMD, but lower power consumption.
Early indications are that the software morphing causes a performance hit.
Tell the truth. My prediction is that once people realize that this company cannot make a significant dent in the portable computer market, the stock price will look like that of an online pet store. Transmeta will then shift its focus to the emerging markets and insist that was its intent all along. That won't help the stock much, though. We were supposed to have learned that betting on hype is a losing proposition.